Nothing Special   »   [go: up one dir, main page]

RU94041682A - Способ получения производных таксана - Google Patents

Способ получения производных таксана

Info

Publication number
RU94041682A
RU94041682A RU94041682/04A RU94041682A RU94041682A RU 94041682 A RU94041682 A RU 94041682A RU 94041682/04 A RU94041682/04 A RU 94041682/04A RU 94041682 A RU94041682 A RU 94041682A RU 94041682 A RU94041682 A RU 94041682A
Authority
RU
Russia
Prior art keywords
general formula
radical
synthesis
taxane derivatives
gmeans
Prior art date
Application number
RU94041682/04A
Other languages
English (en)
Inventor
Депрэ Доминик
Fr]
Пюликани Жан-Пьер
Original Assignee
Рон-Пуленк Роре С.А. (FR)
Рон-Пуленк Роре С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рон-Пуленк Роре С.А. (FR), Рон-Пуленк Роре С.А. filed Critical Рон-Пуленк Роре С.А. (FR)
Publication of RU94041682A publication Critical patent/RU94041682A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/20Processes
    • C25B3/25Reduction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042Electrodes formed of a single material
    • C25B11/043Carbon, e.g. diamond or graphene
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042Electrodes formed of a single material
    • C25B11/046Alloys

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Объектом изобретения является электрохимический способ получения производных таксана общей формулы I, указанной в описании, исходя из продукта общей формулы II, указанной в описании. Продукты общей формулы I имеют замечательные противоопухолевые свойства.

Claims (1)

  1. Объектом изобретения является электрохимический способ получения производных таксана общей формулы I, указанной в описании, исходя из продукта общей формулы II, указанной в описании. Продукты общей формулы I имеют замечательные противоопухолевые свойства.
RU94041682/04A 1992-03-13 1994-09-12 Способ получения производных таксана RU94041682A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9203000A FR2688518B1 (fr) 1992-03-13 1992-03-13 Procede de preparation de derives du taxane.
FR9203000 1992-03-13

Publications (1)

Publication Number Publication Date
RU94041682A true RU94041682A (ru) 1996-07-20

Family

ID=9427641

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94041682/04A RU94041682A (ru) 1992-03-13 1994-09-12 Способ получения производных таксана

Country Status (21)

Country Link
EP (1) EP0630428B1 (ru)
JP (1) JPH07504461A (ru)
KR (1) KR950700439A (ru)
AT (1) ATE130053T1 (ru)
AU (1) AU3756393A (ru)
CA (1) CA2117552A1 (ru)
CZ (1) CZ218694A3 (ru)
DE (1) DE69300766T2 (ru)
DK (1) DK0630428T3 (ru)
ES (1) ES2079982T3 (ru)
FI (1) FI944190A (ru)
FR (1) FR2688518B1 (ru)
GR (1) GR3018036T3 (ru)
HU (1) HUT68282A (ru)
MX (1) MX9301345A (ru)
NO (1) NO943371L (ru)
RU (1) RU94041682A (ru)
SK (1) SK108494A3 (ru)
TW (1) TW235961B (ru)
WO (1) WO1993018210A1 (ru)
ZA (1) ZA931800B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
ES2242807T3 (es) * 1993-03-22 2005-11-16 Florida State University Taxanos que tienen furilo o tienilo sustituido en la cadena lateral sustituida.
US5760251A (en) * 1995-08-11 1998-06-02 Sepracor, Inc. Taxol process and compounds
US6103698A (en) * 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
WO2003085110A2 (en) 2002-04-05 2003-10-16 Santaris Pharma A/S Oligomeric compounds for the modulation hif-1alpha expression
US7713738B2 (en) 2003-02-10 2010-05-11 Enzon Pharmaceuticals, Inc. Oligomeric compounds for the modulation of survivin expression
BRPI0418104A (pt) 2003-12-23 2007-04-17 Santaris Pharma As compostos oligoméricos para a modulação de bcl-2
EP1824975B9 (en) 2004-11-09 2011-04-20 Santaris Pharma A/S Lna oligonucleotides and the treatment of cancer
US9447138B2 (en) 2004-11-09 2016-09-20 Roche Innovation Center Copenhagen A/S Potent LNA oligonucleotides for the inhibition of HIF-1a expression
AU2005304112B2 (en) 2004-11-09 2009-06-04 Roche Innovation Center Copenhagen A/S Potent LNA oligonucleotides for the inhibition of HIF-1a expression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60187689A (ja) * 1984-03-06 1985-09-25 Otsuka Chem Co Ltd 3−エキソメチレンセフアム誘導体の製造法
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
FR2664894A1 (fr) * 1990-07-19 1992-01-24 Rhone Poulenc Sante Nouveaux derives de streptogramines et leur preparation.

Also Published As

Publication number Publication date
GR3018036T3 (en) 1996-02-29
DE69300766D1 (de) 1995-12-14
NO943371D0 (no) 1994-09-12
FI944190A0 (fi) 1994-09-12
CA2117552A1 (fr) 1993-09-16
AU3756393A (en) 1993-10-05
EP0630428A1 (fr) 1994-12-28
JPH07504461A (ja) 1995-05-18
WO1993018210A1 (fr) 1993-09-16
EP0630428B1 (fr) 1995-11-08
ATE130053T1 (de) 1995-11-15
CZ218694A3 (en) 1995-02-15
ES2079982T3 (es) 1996-01-16
DE69300766T2 (de) 1996-04-18
FR2688518A1 (fr) 1993-09-17
ZA931800B (en) 1993-09-30
FR2688518B1 (fr) 1994-05-06
MX9301345A (es) 1993-09-01
HUT68282A (en) 1995-04-03
DK0630428T3 (da) 1995-12-27
HU9402614D0 (en) 1994-11-28
FI944190A (fi) 1994-09-12
NO943371L (no) 1994-09-12
TW235961B (ru) 1994-12-11
KR950700439A (ko) 1995-01-16
SK108494A3 (en) 1995-02-08

Similar Documents

Publication Publication Date Title
PL309293A1 (en) Novel taxoides, methods of obtaining them and pharmaceutical compositions containing such compounds
RU95112464A (ru) Способ получения производных таксана
ATE148882T1 (de) Verfahren zur herstellung von taxan-derivaten
DE69306591D1 (de) Verfahren für die herstellung von toxane derivaten
RU94041682A (ru) Способ получения производных таксана
MX9306606A (es) Procedimiento para la preparacion de derivados de taxano.
RU94031162A (ru) Производные 19-нор-стероидов, имеющих 11-бета-положении тиокарбоновую цепь, способы их получения, фармацевтическая композиция и промежуточные продукты синтеза
DK0687259T3 (da) Fremgangsmåde til fremstilling af taxoider
RU94045799A (ru) СПОСОБ ПОЛУЧЕНИЯ β-ФЕНИЛИЗОСЕРИНА И ЕГО АНАЛОГОВ, СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ТАКСАНА И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ СИНТЕЗА
KR870007902A (ko) 복소환식 화합물
DE69406451D1 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
RU94040727A (ru) Ангидриды кислот, способ их получения, таксаны, способ их получения и фармацевтическая композиция
RU95113420A (ru) Способы получения 1,3-оксазолидин-5-карбоновой кислоты
EA199800767A1 (ru) Производные 1(2h)хинолинкарбоновой кислоты, способ их получения и их применение в синтезе веществ, обладающих антибиотическими свойствами
DE69231512D1 (de) Verfahren zur Isolierung von Carbacephem-Zwischenprodukten
ATE149168T1 (de) Verfahren zur herstellung von einem imidazolderivat
KR920702352A (ko) 비시클로 비대칭 화합물